About UCSF Search UCSF UCSF Medical Center

Dejana Braithwaite, PhD

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
braithwaite_dejana

Assistant Professor, Department of Epidemiology and Biostatistics, UCSF

DBraithwaite@psg-ucsf.org

Phone: (415) 514-8019 (voice)
Box 0560, UCSF
San Francisco, CA 94143-0560

View on UCSF Profiles


Education

1994 University of London, England, German Literature
1998, London Guildhall University, UK, BSc, Psychology/Psychobiology
1999, University College London, UK, MSc, Health Psychology
2004, Cambridge University, Institute of Public Health, UK, PhD, Epidemiology/Behavioral Science
2007, UCSF Breast Cancer Center, Fellowship, Breast Cancer Epidemiology


Professional Experience

  • 2004-2007
    Postdoctoral Fellow, UCSF Helen Diller Family Comprehensive Cancer Center
  • 2007-present
    Assistant Professor, Department of Epidemiology and Biostatistics, University of California, San Francisco, CA

Honors & Awards

  • 2000-04
    Predoctoral Fellowship Award, Cancer Research UK (United Kingdom)
  • 2003
    Scholar in Training Award, American Association for Cancer Research
  • 2007
    Cancer Prevention Research Fellowship from the Prevent Cancer Foundation/American Society for Preventive Oncology
  • 2009
    UCSF Breast Cancer SPORE (Specialized Program of Research Excellence), Developmental Award
  • 2009
    Hellman Family Foundation Award for Early Career Faculty at UCSF
  • 2010
    Best Poster Award, UCSF Breast Oncology Program

Selected Publications

  1. Izano M, Satariano WA, Tammemagi MC, Ragland D, Moore DH, Allen E, Naeim A, Sehl ME, Hiatt RA, Kerlikowske K, Sofrygin O, Braithwaite D. Long-term outcomes among African-American and white women with breast cancer: What is the impact of comorbidity? J Geriatr Oncol. 2014 Jul; 5(3):266-75.
    View on PubMed
  2. Izano M, Satariano WA, Hiatt RA, Braithwaite D. The impact of functional limitations on long-term outcomes among African-American and white women with breast cancer: a cohort study. BMJ Open. 2013; 3(10):e003232.
    View on PubMed
  3. O'Meara ES, Zhu W, Hubbard RA, Braithwaite D, Kerlikowske K, Dittus KL, Geller B, Wernli KJ, Miglioretti DL. Mammographic screening interval in relation to tumor characteristics and false-positive risk by race/ethnicity and age. Cancer. 2013 Nov 15; 119(22):3959-67.
    View on PubMed
  4. Wernli KJ, Kitahara CM, Tamers SL, Al-Temimi MH, Braithwaite D. Undertaking cancer research in international settings: report from the american society for preventive oncology special interest group on international issues in cancer. Cancer Epidemiol Biomarkers Prev. 2013 Sep; 22(9):1638-41.
    View on PubMed
  5. Castillo-Trivino T, Braithwaite D, Bacchetti P, Waubant E. Rituximab in relapsing and progressive forms of multiple sclerosis: a systematic review. PLoS One. 2013; 8(7):e66308.
    View on PubMed
  6. Dittus K, Geller B, Weaver DL, Kerlikowske K, Zhu W, Hubbard R, Braithwaite D, O'Meara ES, Miglioretti DL. Impact of mammography screening interval on breast cancer diagnosis by menopausal status and BMI. J Gen Intern Med. 2013 Nov; 28(11):1454-62.
    View on PubMed
  7. Braithwaite D, Mandelblatt JS, Kerlikowske K. To screen or not to screen older women for breast cancer: a conundrum. Future Oncol. 2013 Jun; 9(6):763-6.
    View on PubMed
  8. Kerlikowske K, Zhu W, Hubbard RA, Geller B, Dittus K, Braithwaite D, Wernli KJ, Miglioretti DL, O'Meara ES. Outcomes of screening mammography by frequency, breast density, and postmenopausal hormone therapy. JAMA Intern Med. 2013 May 13; 173(9):807-16.
    View on PubMed
  9. Braithwaite D, Zhu W, Hubbard RA, O'Meara ES, Miglioretti DL, Geller B, Dittus K, Moore D, Wernli KJ, Mandelblatt J, Kerlikowske K. Screening outcomes in older US women undergoing multiple mammograms in community practice: does interval, age, or comorbidity score affect tumor characteristics or false positive rates? J Natl Cancer Inst. 2013 Mar 6; 105(5):334-41.
    View on PubMed
  10. Braithwaite D, Izano M, Moore DH, Kwan ML, Tammemagi MC, Hiatt RA, Kerlikowske K, Kroenke CH, Sweeney C, Habel L, Castillo A, Weltzien E, Caan B. Smoking and survival after breast cancer diagnosis: a prospective observational study and systematic review. Breast Cancer Res Treat. 2012 Nov; 136(2):521-33.
    View on PubMed
  11. Braithwaite D, Boffetta P, Rebbeck TR, Meyskens F. Cancer prevention for global health: a report from the ASPO International Cancer Prevention Interest Group. Cancer Epidemiol Biomarkers Prev. 2012 Sep; 21(9):1606-10.
    View on PubMed
  12. Braithwaite D, Moore DH, Satariano WA, Kwan ML, Hiatt RA, Kroenke C, Caan BJ. Prognostic impact of comorbidity among long-term breast cancer survivors: results from the LACE study. Cancer Epidemiol Biomarkers Prev. 2012 Jul; 21(7):1115-25.
    View on PubMed
  13. Rehkopf DH, Laraia BA, Segal M, Braithwaite D, Epel E. The relative importance of predictors of body mass index change, overweight and obesity in adolescent girls. Int J Pediatr Obes. 2011 Jun; 6(2-2):e233-42.
    View on PubMed
  14. Braithwaite D, Satariano WA, Sternfeld B, Hiatt RA, Ganz PA, Kerlikowske K, Moore DH, Slattery ML, Tammemagi M, Castillo A, Melisko M, Esserman L, Weltzien EK, Caan BJ. Long-term prognostic role of functional limitations among women with breast cancer. J Natl Cancer Inst. 2010 Oct 6; 102(19):1468-77.
    View on PubMed
  15. Glasspool DW, Oettinger A, Braithwaite D, Fox J. Interactive decision support for risk management: a qualitative evaluation in cancer genetic counselling sessions. J Cancer Educ. 2010 Sep; 25(3):312-6.
    View on PubMed
  16. Braithwaite D, Wernli KJ, Anton-Culver H, Engstrom P, Greenberg ER, Meyskens F. Opportunities for cancer epidemiology and control in low- and middle-income countries: a report from the american society for preventive oncology international cancer prevention interest group. Cancer Epidemiol Biomarkers Prev. 2010 Jul; 19(7):1665-7.
    View on PubMed
  17. Joseph G, Beattie MS, Lee R, Braithwaite D, Wilcox C, Metrikin M, Lamvik K, Luce J. Pre-counseling education for low literacy women at risk of Hereditary Breast and Ovarian Cancer (HBOC): patient experiences using the Cancer Risk Education Intervention Tool (CREdIT). J Genet Couns. 2010 Oct; 19(5):447-62.
    View on PubMed
  18. Braithwaite D, Tammemagi CM, Moore DH, Ozanne EM, Hiatt RA, Belkora J, West DW, Satariano WA, Liebman M, Esserman L. Hypertension is an independent predictor of survival disparity between African-American and white breast cancer patients. Int J Cancer. 2009 Mar 1; 124(5):1213-9.
    View on PubMed
  19. Braithwaite D, Moore DH, Lustig RH, Epel ES, Ong KK, Rehkopf DH, Wang MC, Miller SM, Hiatt RA. Socioeconomic status in relation to early menarche among black and white girls. Cancer Causes Control. 2009 Jul; 20(5):713-20.
    View on PubMed
  20. Ozanne EM, Braithwaite D, Sepucha K, Moore D, Esserman L, Belkora J. Sensitivity to input variability of the Adjuvant! Online breast cancer prognostic model. J Clin Oncol. 2009 Jan 10; 27(2):214-9.
    View on PubMed

Go to UCSF Profiles, powered by CTSI